Nandini Venkateswaran, MD
Ophthalmology · Waltham, MANPI 1265813992
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $120,708 of the $148,592 with a category attached, or 81.2%. 25 manufacturers reported payments, led by Tarsus Pharmaceuticals, Inc. at 26.6% of the total. Among ophthalmology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 251 payments — averaging $592.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tarsus Pharmaceuticals, Inc.$40K
- Johnson & Johnson Surgical Vision, Inc.$23K
- Alcon$20K
- Thea Pharma Inc.$19K
- Sight Sciences, Inc.$12K
- Glaukos Corporation$8K
- plus $28K from 19 others
Across 2 payments — averaging $32,651 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$65K
What the payments were for
- Consulting fees$120,70881%
- Speaking & faculty fees$15,46510%
- Travel & lodging$250%
- Food & beverage$12,3768%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 15 | $39,526 |
| Johnson & Johnson Surgical Vision, Inc. | 20 | $22,531 |
| Alcon | 75 | $19,681 |
| Thea Pharma Inc. | 8 | $18,771 |
| Sight Sciences, Inc. | 17 | $11,541 |
| Glaukos Corporation | 17 | $8,422 |
| Carl Zeiss Meditec, Inc. | 7 | $8,121 |
| AbbVie(2 entities) | 21 | $7,255 |
| Bausch & Lomb Americas Inc. | 8 | $3,784 |
| Ocular Therapeutix, Inc. | 15 | $3,198 |
| Beaver-visitec International, Inc. | 3 | $1,807 |
| Dompe US, Inc. | 14 | $1,576 |
| Sun Pharmaceutical Industries Inc. | 6 | $506 |
| Oyster Point Pharma, Inc. | 6 | $469 |
| Regeneron Healthcare Solutions, Inc. | 2 | $270 |
| Novartis | 3 | $229 |
| Harrow Eye, LLC | 4 | $222 |
| Johnson & Johnson Vision Care, Inc. | 1 | $171 |
| Shire North American Group Inc | 1 | $122 |
| Apellis Pharmaceuticals, Inc. | 1 | $118 |
| Rxsight Inc | 2 | $99 |
| Aerie Pharmaceuticals, Inc. | 1 | $70 |
| Kala Pharmaceuticals, Inc. | 2 | $64 |
| Rayner Intraocular Lenses Limited | 1 | $26 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XDEMVY$35,689
- Tecnis IOL$25,599
- Tecnis Simplicity$19,922
- VERITAS Vision System$16,149
- VisuMax$7,400
- VUITY$4,884
- OMNI(R) SURGICAL SYSTEM (US)$4,875
- SION SURGICAL INSTRUMENT$4,875
- TEARCARE SYSTEM$3,375
- Discovisc$3,185
- XIIDRA$3,165
- TearCare SmartLid$3,119
- TEARCARE(TM) (2.2) SYSTEM KIT$3,119
- AcrySof$3,043
- AcrySof IQ PanOptix UV IOL$3,000
- AcrySof IQ VIVITY$3,000
- MIEBO$2,936
- DEXTENZA$2,757
- CE-marked KXLA system$2,450
- CATALYS SYSTEM$2,250
How this compares
$148,592 in reported general payments places this provider in the 95th percentile of 653 ophthalmology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 70 | $61,050 |
| MieboPerfluorohexyloctane/Pf | 69 | $58,644 |
| TyrvayaVarenicline Tartrate | 54 | $39,614 |
| XiidraLifitegrast | 33 | $28,632 |
| CequaCyclosporine | 19 | $19,920 |
| AzasiteAzithromycin | 21 | $15,011 |
| ZirganGanciclovir | 25 | $12,050 |
| Cyclosporine | 39 | $10,020 |
| Bromfenac Sodium | 47 | $9,609 |
| Prednisolone Acetate | 268 | $8,794 |
| RhopressaNetarsudil Mesylate | 15 | $5,883 |
| Loteprednol Etabonate | 34 | $3,881 |
| ValacyclovirValacyclovir Hcl | 88 | $3,677 |
| Difluprednate | 20 | $2,261 |
| MoxifloxacinMoxifloxacin Hcl | 104 | $2,059 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Miebo, Xiidra, Zirgan | $3,784 | $99,326127 claims |
| AbbVieRestasis | $7,255 | $61,05070 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $469 | $39,61454 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $506 | $19,92019 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa | $70 | $5,88315 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $12 | $3,88134 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 653 ophthalmology providers in Massachusetts.
Other ophthalmology in Waltham
- Peter ChangWaltham$992K
- Stephen AnesiWaltham$922K
- Jonathan TalamoWaltham$225K
- Charles FosterWaltham$24K
- Rishi SinghBoston$1.7M
- David LallySpringfield$328K
- Adam RogersBoston$316K
- Bonnie HendersonBoston$279K
- Mark LatinaReading$279K
- Dean EliottBoston$250K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.